Active substance
Beclometasone
- SFDA 12
- US FDA 14
- EMA 1
- Health Canada 5
- US price lines 3
- NHS prices 11
- WHO EML 1
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CLENIL FORTE 250MCG PUFF METERED INHALER | 250 µg | Pressurised inhalation, solution · Inhalation use | 1 Pressurised container | SAR 73.60 | NCE · Prescription | CHIESI FARMACEUTICIS | Valid |
| IBICAR 250 MCG INHALATION | 250 µg | Pressurised inhalation · Inhalation use | 200 Pressurised container | SAR 24.05 | Generic · Prescription | Glenmark Pharmaceuticals Limited | Valid |
| RINOCLENIL 100MCG-DOSE NASAL SPRAY | 100 µg | Nasal spray · Nasal use | 1 Nasal Applicator | SAR 44.95 | Generic · Prescription | CHIESI FARMACEUTICIS | Valid |
| BECLAZONE 100MCG CFC-FREE INHALER | 100 µg | Solution · Inhalation use | 1 Pressurised container | SAR 42.00 | Generic · Prescription | IVAX PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| BECLAZONE 100MCG EASI-BREATHE INHALER | 100 µg | Solution · Inhalation use | 200 Inhaler | SAR 51.65 | Generic · Prescription | IVAX PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| BECLAZONE 250MCG CFC-FREE INHALER | 250 µg | Solution · Inhalation use | 1 Pressurised container | SAR 96.30 | Generic · Prescription | IVAX PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| BECLAZONE 250MCG EASI-BREATHE INHALER | 250 µg | Solution · Inhalation use | 1 Pressurised container | SAR 105.95 | Generic · Prescription | IVAX PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| BECLAZONE 50MCG CFC-FREE INHALER | 50 µg | Solution · Inhalation use | 1 Pressurised container | SAR 21.05 | Generic · Prescription | IVAX PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| BECLAZONE 50MCG EASI-BREATHE INHALER | 50 µg | Solution · Inhalation use | 200 Inhaler | SAR 30.70 | Generic · Prescription | IVAX PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| BECLOHALE 250MCG-DOSE INHALER | 0.25 mg | Pressurised inhalation · Inhalation use | 1 Pressurised container | SAR 69.50 | NCE · Prescription | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
| BECONASE AQUEOUS NASAL SPRAY | 50 µg | Spray · Nasal use | 1 Nasal Applicator | SAR 15.70 | Generic · Prescription | GLAXO SAUDI ARABIA | Withdrawn by MAH · Not Marketed |
| RINO-CLENIL 50MCG-PUFF NASAL SPRAY SOLU. | 50 µg | Nasal spray · Nasal use | 1 Nasal Applicator | SAR 25.55 | NCE · Prescription | CHIESI FARMACEUTICIS | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ASTHMA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD); MUCOSAL ULCERATION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| QNASL | 0.08MG/ACTUATION; 0.04MG/ACTUATION | aerosol, metered · nasal | TEVA BRANDED PHARM | Prescription | 23 Mar 2012 |
| QVAR REDIHALER | 0.04MG/INH; 0.08MG/INH | aerosol, metered · inhalation | NORTON WATERFORD | Prescription | 3 Aug 2017 |
| BECLOMETHASONE DIPROPIONATE | 0.04MG/INH; 0.08MG/INH | aerosol, metered · inhalation | AMNEAL IRELAND LTD | Prescription | 16 Dec 2025 |
| BECLOMETHASONE DIPROPIONATE | 0.04MG/INH; 0.08MG/INH | aerosol, metered · inhalation | AUROLIFE PHARMA LLC | Prescription | 14 Sep 2026 |
| VANCERIL | 0.042MG/INH | aerosol, metered · inhalation | SCHERING | Discontinued | 12 May 1976 |
| BECLOVENT | 0.042MG/INH | aerosol, metered · inhalation | GLAXOSMITHKLINE | Discontinued | 24 Jun 1980 |
| VANCENASE | 0.042MG/INH | aerosol, metered · nasal | SCHERING | Discontinued | 24 Sep 1981 |
| BECONASE | 0.042MG/INH | aerosol, metered · nasal | GLAXOSMITHKLINE | Discontinued | 30 Sep 1981 |
| BECONASE AQ | EQ 0.042MG DIPROP/SPRAY | spray, metered · nasal | GLAXOSMITHKLINE | Discontinued | 27 Jul 1987 |
| VANCENASE AQ | EQ 0.042MG DIPROP/SPRAY | spray, metered · nasal | SCHERING | Discontinued | 23 Dec 1987 |
| VANCENASE AQ | EQ 0.084MG DIPROP/SPRAY | spray, metered · nasal | SCHERING | Discontinued | 26 Jun 1996 |
| VANCERIL DOUBLE STRENGTH | 0.084MG/INH | aerosol, metered · inhalation | SCHERING | Discontinued | 24 Dec 1996 |
| QVAR 80 | 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | aerosol, metered · inhalation | TEVA BRANDED PHARM | Discontinued | 15 Sep 2000 |
| QVAR 40 | 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | aerosol, metered · inhalation | TEVA BRANDED PHARM | Discontinued | 15 Sep 2000 |
EMA European Union — centrally authorised medicines
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-BECLOMETHASONE NASAL SPRAY | 02238796 | 50 MCG / ACT | SUSPENSION · NASAL | APOTEX INC |
| MYLAN-BECLO AQ | 02172712 | 50 MCG / ACT | AEROSOL (METERED-DOSE); SUSPENSION · NASAL | MYLAN PHARMACEUTICALS ULC |
| PROPADERM | 02089602 | 0.025 % / W/W | CREAM · TOPICAL | BAUSCH HEALTH, CANADA INC. |
| QVAR | 02242029 | 50 MCG / ACT | AEROSOL (METERED-DOSE) · INHALATION | BAUSCH HEALTH, CANADA INC. |
| QVAR | 02242030 | 100 MCG / ACT | AEROSOL (METERED-DOSE) · INHALATION | BAUSCH HEALTH, CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | QNASL 80 MCG NASAL SPRAY | $30.22549 | per GM | 23 Sep 2026 |
| US NADAC | QVAR REDIHALER 40 MCG | $20.56589 | per GM | 23 Sep 2026 |
| US NADAC | QVAR REDIHALER 80 MCG | $27.56579 | per GM | 23 Sep 2026 |
| NHS Drug Tariff | Beclometasone 0.025% cream | £74.97 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 0.025% ointment | £74.97 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 100micrograms/dose breath actuated inhaler CFC free | £17.21 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 100micrograms/dose inhaler CFC free | £7.42 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 200micrograms/dose dry powder inhaler | £14.93 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 200micrograms/dose inhaler CFC free | £16.17 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 250micrograms/dose inhaler CFC free | £16.29 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 50micrograms/dose breath actuated inhaler CFC free | £7.87 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 50micrograms/dose inhaler CFC free | £3.70 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 50micrograms/dose nasal spray | £2.63 | 200 dose | 1 Oct 2026 |
| NHS Drug Tariff | Beclometasone 5mg gastro-resistant modified-release tablets | £56.56 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease · core
Therapeutic equivalent to budesonide for Asthma
Safety signals and safety-related labeling changes
- US FDA 26 Sep 2025 QVAR REDIHALER — safety-related labeling change
Labeling sections changed: Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 12 Apr 2019 BECONASE AQ — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 29 Sep 2017 QVAR 40 — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 29 Sep 2017 QVAR 80 — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 26 Jul 2017 QNASL — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Beclometasone
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.